These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32894819)

  • 1. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
    McLean L; Hong W; McLachlan SA
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
    Durber K; Halkett GK; McMullen M; Nowak AK
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
    Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
    Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.
    Dussel V; Bona K; Heath JA; Hilden JM; Weeks JC; Wolfe J
    J Clin Oncol; 2011 Mar; 29(8):1007-13. PubMed ID: 21205758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
    Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
    Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Impact on Australian Patients with Neuroendocrine Tumours.
    Gordon LG; Elliott TM; Wakelin K; Leyden S; Leyden J; Michael M; Pavlakis N; Mumford J; Segelov E; Wyld DK
    Patient; 2020 Jun; 13(3):363-373. PubMed ID: 32072460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
    Bhoo-Pathy N; Ng CW; Lim GC; Tamin NSI; Sullivan R; Bhoo-Pathy NT; Abdullah MM; Kimman M; Subramaniam S; Saad M; Taib NA; Chang KM; Goh PP; Yip CH
    J Oncol Pract; 2019 Jun; 15(6):e537-e546. PubMed ID: 31112479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
    Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
    Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
    Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
    Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.
    Yap SL; Wong SS; Chew KS; Kueh JS; Siew KL
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3077-3083. PubMed ID: 33112570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
    D'Rummo KA; Miller L; TenNapel MJ; Shen X
    Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
    Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
    Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
    [No Abstract]   [Full Text] [Related]  

  • 16. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
    Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
    Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
    Kiely F; Cran A; Finnerty D; O'Brien T
    Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer.
    Thom B; Benedict C
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):236-242. PubMed ID: 30817217
    [No Abstract]   [Full Text] [Related]  

  • 19. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national cross-sectional survey of financial toxicity among bladder cancer patients.
    Ehlers M; Bjurlin M; Gore J; Pruthi R; Narang G; Tan R; Nielsen M; Zhu A; Deal A; Smith A
    Urol Oncol; 2021 Jan; 39(1):76.e1-76.e7. PubMed ID: 33268274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.